[1]朱培雯,史学佳,秦士杰,等.竞争性结合的LncRNA和miRNA作为标志物提高宫颈鳞癌患者的诊断和预后[J].南京师大学报(自然科学版),2020,43(04):53-61.[doi:10.3969/j.issn.1001-4616.2020.04.009]
　Zhu Peiwen,Shi Xuejia,Qin Shijie,et al.LncRNAs and miRNAs from a ceRNA Network as a Signature CanImprove the Diagnosis and Prognosis of CESC Patients[J].Journal of Nanjing Normal University(Natural Science Edition),2020,43(04):53-61.[doi:10.3969/j.issn.1001-4616.2020.04.009]
点击复制

竞争性结合的LncRNA和miRNA作为标志物提高宫颈鳞癌患者的诊断和预后()
分享到：

《南京师大学报（自然科学版）》[ISSN:1001-4616/CN:32-1239/N]

卷:
第43卷
期数:
2020年04期
页码:
53-61
栏目:
·生物学·
出版日期:
2020-12-30

文章信息/Info

Title:
LncRNAs and miRNAs from a ceRNA Network as a Signature CanImprove the Diagnosis and Prognosis of CESC Patients
文章编号:
1001-4616(2020)04-0053-09
作者:
朱培雯1; 史学佳2; 秦士杰2; 廖 敏1; 马 飞2
(1.安徽农业大学植物保护学院,安徽 合肥 230036)(2.南京师范大学生命科学学院,江苏 南京 210023)
Author(s):
Zhu Peiwen1; Shi Xuejia2; Qin Shijie2; Liao Min1; Ma Fei2
(1.School of Plant Protection,Anhui Agricultural University,Hefei 230036,China)(2.School of Life Sciences,Nanjing Normal University,Nanjing 210023,China)
关键词:
宫颈鳞状细胞癌; lncRNA; miRNA; ceRNA网络; 预后因子
Keywords:
cervical squamous cell carcinoma(CESC); lncRNA; miRNA; ceRNA network; prognostic factor
分类号:
R737
DOI:
10.3969/j.issn.1001-4616.2020.04.009
文献标志码:
A
摘要:
宫颈鳞状细胞癌(CESC)严重损害了全世界妇女的健康. 因此,寻找新的诊断和预后因子对提高CESC的预防和治疗具有重要价值. 为了进一步筛选出有效的生物标志物提高CESC患者的诊断和预后,论文系统地研究了来自癌基因组图谱(TCGA)数据库中的lncRNA、miRNA和mRNA表达情况. 研究鉴定了25个lncRNA、14个miRNA和371个mRNA与CESC患者的生存相关; 构建了一个与生存相关的lncRNA-miRNA-mRNA 竞争性调节网络(ceRNA); 发现2个lncRNA(TP73-AS1、CASC15)和3个miRNA(hsa-MiR-142-3p、hsa-MiR-128-3p、hsa-MiR-642a-5p)能够作为CESC的诊断和预后生物标志物,特别是上调的TP73-AS1和CASC15可以作为不良预后因子,而上调的hsa-MiR-142-3p、hsa-MiR-128-3p和hsa-MiR-642a-5p可作为CESC患者生存的良好预后因子. 论文研究表明,联合TP73-AS1、CASC15、hsa-MiR-128-3p、hsa-MiR-142-3p和hsa-MiR-642a-5p的预后模型能显著提高CESC患者的预后和可信度. 研究不仅为CESC患者确定了几种新颖的诊断和预后因子,而且也揭示了改善CESC患者生存的潜在机制.
Abstract:
Cervical squamous cell carcinoma(CESC)seriously harms women’s health worldwide. Therefore,it is of great value to find new diagnostic and prognostic factors to improve the prevention and treatment of CESC. To further screen out effectively biomarkers for promoting the diagnosis and prognosis of CESC patients,it was here systematically investigated the expression landscapes of lncRNAs,miRNAs and mRNAs from The Cancer Genome Atlas(TCGA). In this work,it was firstly identified 25 lncRNAs,14 miRNAs and 371 genes associated with CESC patients’ survival. Secondly,it constructed a survival-related lncRNA-miRNA-mRNA ceRNA network. Thirdly,it was discovered that 2 lncRNAs(TP73-AS1 and CASC15),3 miRNAs(hsa-MiR-142-3p,hsa-MiR-128-3p and hsa-MiR-642a-5p)could be used as promising diagnostic and prognostic biomarkers for CESC,in particular highly expressed TP73-AS1 and CASC15 could act as poor prognostic factors,whereas highly expressed hsa-MiR-142-3p,hsa-MiR-128-3p and hsa-MiR-642a-5p could serve as good prognostic factors for the survival of CESC patients. Finally,our results demonstrated that a signature containing TP73-AS1,CASC15,hsa-MiR-142-3p,hsa-MiR-128-3p and hsa-MiR-642a-5p could significantly facilitate the prognosis and credibility of CESC patients. Taken together,our present study identified several novel diagnostic and prognostic factors for CESC patients,and revealed a potential mechanism of facilitating the survival of CESC patients.

参考文献/References:

[1] OJESINA A I,LICHTENSTEIN L,FREEMAN S S,et al. Landscape of genomic alterations in cervical carcinomas[J]. Nature,2014,506(7488):371-375.
[2]YOSHIDA K,KAJIYAMA H,UTSUMI F,et al. A post-recurrence survival-predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence[J]. Molecular and clinical oncology,2018,8(2):281-285.
[3]MATKOVICH S J,VAN BOOVEN D J,ESCHENBACHER W H,et al. RISC RNA sequencing for context-specific identification of in vivo microRNA targets[J]. Circulation research,2011,108(1):18-26.
[4]RINN J L,CHANG H Y. Genome regulation by long noncoding RNAs[J]. Annual review of biochemistry,2012,81:145-166.
[5]WANG X,HU K B,ZHANG Y Q,et al. Comprehensive analysis of aberrantly expressed profiles of lncRNAs,miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma[J]. Cancer biomarkers:section A of disease markers,2018,23(4):549-559.
[6]SALMENA L,POLISENO L,TAY Y,et al. A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?[J]. Cell,2011,146(3):353-358.
[7]XIE Q,LIN S,ZHENG M,et al. Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging MiR-9-5p[J]. Biochemistry and cell biology(Biochimie et biologie cellulaire),2019,97(2):100-108.
[8]LIN P,WEN D Y,LI Q,et al. Genome-wide analysis of prognostic lncRNAs,miRNAs,and mRNAs forming a competing endogenous RNA network in hepatocellular carcinoma[J]. Cellular physiology and biochemistry:international journal of experimental cellular physiology,biochemistry,and pharmacology,2018,48(5):1953-1967.
[9]YU G,WANG L G,HAN Y,et al. clusterProfiler:an R package for comparing biological themes among gene clusters[J]. Omics:a journal of integrative biology,2012,16(5):284-287.
[10]PLAISIER C L,PAN M,BALIGA N S. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers[J]. Genome research,2012,22(11):2302-2314.
[11]XIN X,ZHANG Y,LING F,et al. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma[J]. Experimental eye research,2019,180:242-249.
[12]CHEN W,CHEN X,WANG Y,et al. Construction and analysis of lncRNA-mediated ceRNA network in cervical squamous cell carcinoma by weighted gene Co-expression network analysis[J]. Medical science monitor:international medical journal of experimental and clinical research,2019,25:2609-2622.
[13]JIANG D,WANG H,LI Z,et al. MiR-142 inhibits the development of cervical cancer by targeting HMGB1[J]. Oncotarget,2017,8(3):4001-4007.
[14]ZHU L,TU H,LIANG Y,et al. MiR-218 produces anti-tumor effects on cervical cancer cells in vitro[J]. World journal of surgical oncology,2018,16(1):204.
[15]MA C,ZHANG W,WU Q,et al. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma[J]. PloS one,2018,13(3):e0193625.
[16]XU J,ZHANG J. LncRNA TP73-AS1 is a novel regulator in cervical cancer via MiR-329-3p/ARF1 axis[J]. Journal of cellular biochemistry,2020,121(1):344-352.
[17]SHAN S,LI H F,YANG X Y,et al. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer[J]. European review for medical and pharmacological sciences,2019,23(2):507-512.
[18]SONG J,YE A,JIANG E,et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC[J]. Journal of cellular biochemistry,2018,119(8):6665-6673.
[19]YUAN M,CHENG J,LIU Y,et al. Screening and functional analysis of microRNA expression in HPV16-positive squamous carcinoma of the cervix in the Uygur of southern Xinjiang[J]. Journal of Central South university medical sciences,2015,40(7):701-709.
[20]LI W Y,LI Q W,HAN Z S,et al. Growth suppression effects of recombinant adenovirus expressing human lactoferrin on cervical cancer in vitro and in vivo[J]. Cancer biotherapy & radiopharmaceuticals,2011,26(4):477-483.
[21]HE M,CHENG Y,LI W,et al. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade[J]. BMC cancer,2010,10:170.
[22]ZHANG L,JIANG Y,LU X,et al. Genomic characterization of cervical cancer based on human papillomavirus status[J]. Gynecologic oncology,2019,152(3):629-637.
[23]YANG F,GUO L,CAO Y,et al. MicroRNA-7-5p Promotes cisplatin resistance of cervical cancer cells and modulation of cellular energy homeostasis by regulating the expression of the PARP-1 and BCL2 Genes[J]. Medical science monitor:international medical journal of experimental and clinical research,2018,24:6506-6516.
[24]WIDSCHWENDTER A,MULLER H M,FIEGL H,et al. DNA methylation in serum and tumors of cervical cancer patients[J]. Clinical cancer research:an official journal of the American association for cancer research,2004,10(2):565-571.

备注/Memo

备注/Memo:
收稿日期:2020-06-05.
基金项目:国家自然科学基金面上项目(31970477).
通讯作者:马飞,教授,博士生导师,研究方向:分子免疫与生物信息. E-mail:mafei01@tsinghua.org.cn
更新日期/Last Update: 2020-11-15